Clinical trial
A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine…
NCT00500149 · Shire, Industry · Completed
Key facts
| NCT number | NCT00500149 |
|---|---|
| Title | A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD) |
| Official title | A Phase IIIb, Randomized, Double-Blind, Multi-Center, Placebo- Controlled, Dose-Optimization, Cross-Over, Analog Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ADHD |
| Intervention type | Drug |
| Interventions | Vyvanse (lisdexamfetamine dimesylate), Placebo |
| Enrollment | 129 |
| Start date | Jun 13, 2007 |
| Primary completion | Dec 5, 2007 |
| Completion | Dec 5, 2007 |
| First posted | Jul 12, 2007 |
| Last update posted | Jun 14, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: